IDEAYA Biosciences
Nasdaq IDYA · South San Francisco, CA
Works in Dermatology · Genetic & rare · GI & liver · Metabolic & endocrine · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
IDEAYA Biosciences is a clinical trial sponsor based in South San Francisco, CA, listed as Nasdaq IDYA. It has 11 active clinical trials with 3,103 planned participants, across 10 therapeutic areas.
Trial track record · since 2021
Financials · Nasdaq IDYA
Fundraising
Pipeline · 11 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about IDEAYA Biosciences
IDEAYA Biosciences is lead sponsor of 11 active clinical trials on ClinicalTrials.gov, with 3,103 planned participants, in Dermatology, Genetic & rare, GI & liver, Metabolic & endocrine and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
IDEAYA Biosciences is based in South San Francisco, CA and is listed as Nasdaq IDYA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with IDEAYA Biosciences; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-28.
Approve Suite is not affiliated with IDEAYA Biosciences.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.